Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, T-cell and B-cell Immunology, Immune Cell Function and Interaction, and CRISPR and Genetic Engineering.
In vivo site-specific engineering to reprogram T cells
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes
Base-editing mutagenesis maps alleles to tune human T cell functions
An evolved AAV variant enables efficient genetic engineering of murine T cells